SCHEMBL4244807

SCHEMBL4244807

COC(=O)C1=C(O)C(Cc2ccccc2)NC1=O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR0B1 P51843 1/20 0.61
ALDH1A1 P00352 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
LMNA P02545 2/20 0.41
RNASEH1 O60930 1/20 0.40
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
PLA2G10 O15496 1/20 0.38
PLA2G5 P39877 1/20 0.38
PSEN1 P49768 1/20 0.38
PSEN2 P49810 1/20 0.38
APH1B Q8WW43 1/20 0.38
NCSTN Q92542 1/20 0.38
APH1A Q96BI3 1/20 0.38
PSENEN Q9NZ42 1/20 0.38
TSHR P16473 1/20 0.38
FGFR1 P11362 1/20 0.38
SRC P12931 1/20 0.38
FGFR2 P21802 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4241297 0.86 NR0B1 (0.46) NR0B1ALDH1A1MEN1KMT2ALMNA
SCHEMBL4244260 0.86 KMT2A (0.54) NR0B1ALDH1A1MEN1KMT2ALMNA
SCHEMBL28620615 0.84 NR0B1 (0.69) NR0B1LMNAALOX15PLA2G10PLA2G5
SCHEMBL4246713 0.84 NR0B1 (0.64) NR0B1ALOX15PLA2G10PLA2G5
SCHEMBL28622931 0.82 NR0B1 (0.47) NR0B1ALDH1A1MEN1KMT2ALMNA
SCHEMBL13744100 0.80 NR0B1 (0.51) NR0B1ALDH1A1MEN1KMT2ALMNA
SCHEMBL4244324 0.77 ALDH1A1 (0.41) NR0B1ALDH1A1MEN1KMT2ALMNA
SCHEMBL4241352 0.77 NR0B1 (0.40) NR0B1ALDH1A1LMNARNASEH1HPGD
SCHEMBL29464991 0.76 NR0B1 (1.00) NR0B1ALDH1A1MEN1KMT2ALMNA
SCHEMBL13743665 0.76 NR0B1 (0.52) NR0B1MEN1KMT2ALMNAALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113402436-B Tertiary amino acid derivative, preparation method and application thereof 安徽农业大学 2024-07-12 CN disclosed
CN-113402436-A Trolamine derivatives, preparation method and application thereof 安徽农业大学 2021-09-17 CN disclosed
US-20090203694-A1 INHIBITORS OF UNDECAPRENYL PYROPHOSPHATE SYNTHASE HURLEY TIMOTHY BRIAN 2009-08-13 US disclosed
US-20090203694-A1 INHIBITORS OF UNDECAPRENYL PYROPHOSPHATE SYNTHASE HURLEY TIMOTHY BRIAN 2009-08-13 US disclosed
US-20090203694-A1 INHIBITORS OF UNDECAPRENYL PYROPHOSPHATE SYNTHASE HURLEY TIMOTHY BRIAN 2009-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203694-A1 INHIBITORS OF UNDECAPRENYL PYROPHOSPHATE SYNTHASE FDPS, UMPS, GGPS1 NR0B1 2001/4885ALDH1A1 3119/4885MEN1 2345/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.